BIOLOGICAL · Unmapped registry intervention
peripheral blood lymphocyte therapy
Find medicine records ·
Find other trials using this name
Clinical trial
Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
NCT00003887
Study summary
ClinicalTrials.govLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Loading study purpose, treatment groups and outcomes…
View the complete registry record, eligibility and contacts at ClinicalTrials.gov
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Advertisement
Conditions
Breast Cancerverified · MONDO: breast cancer
Chronic Myeloproliferative Disordersunresolved
Kidney Cancerverified · MONDO: kidney cancer
Leukemiaverified · MONDO: leukemia
Lymphomaverified · MONDO: lymphoma
Neuroblastomaverified · MONDO: neuroblastoma
Ovarian Cancerverified · MONDO: ovarian cancer
Sarcomaverified · MONDO: sarcoma
Interventions
peripheral blood lymphocyte therapyBIOLOGICAL
Sponsors & collaborators
Fred Hutchinson Cancer Centerlead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00003887 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.